関連する実験動画
Updated: Jun 23, 2026
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
VMA21欠乏症:ミオサイト消化不良の症例
Michio Hirano1, Salvatore DiMauro
1Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA. mh29@columbia.edu
Cell
|April 22, 2009
まとめ
VMA21遺伝子の変異は,過剰なオートファギーを伴うX関連ミオパシーを引き起こす. この研究は,VMA21タンパク質機能とこのまれな遺伝疾患を結びつける予期せぬメカニズムを明らかにしています.
科学分野:
- 細胞生物学 細胞生物学
- 分子遺伝学 分子遺伝学
- 人間の病気 ヒトの病気
背景:
- Vma21pは酵母タンパク質で,細胞の重要なプロトンポンプである真空のATPアゼの組み立てに不可欠です.
- 真空のATPアゼは,膜取引やpHホメオスタシスを含む多数の細胞機能を調節する.
研究 の 目的:
- ヒトのVMA21遺伝子の突然変異が,過剰なオートファギーを伴うX関連ミオパシーにつながるメカニズムを調査する.
- 人間の細胞機能と疾患の病原性におけるVMA21タンパク質の役割を明らかにする.
主な方法:
- VMA21変異の遺伝子解析.
- タンパク質の機能と局所化を研究するための細胞および生化学的分析.
- 影響を受けた細胞におけるオートファギー評価.
主要な成果:
- ヒトのVMA21遺伝子の突然変異が,過剰なオートファギーを伴うX関連ミオパシーの原因として特定されました.
- VMA21の機能不全が疾患のフェノタイプにつながる予期せぬメカニズムが実証されました.
- バクオラーATPASEアセンブリにおけるその機能を通じて,オートファギーの調節におけるVMA21の役割を強調した.
結論:
- VMA21は,真空アテパースの適切な組立とヒトの機能に不可欠です.
- 機能不全のVMA21は,新しい経路経由で過剰なオートファギーを伴うX関連ミオパシーにつながる.
- VMA21の役割を理解することで,細胞膜の動力学と自滅性疾患の洞察が得られます.
関連する概念動画
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...